An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the antitussive effect size and dose response of
FP01 lozenges in subjects with chronic cough and to demonstrate the safety and tolerability
of FP01 lozenges in subjects with chronic cough.